Dong-Joo Cheon

9PUBLICATIONS
29CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 26, 2026
Lipidomic Profiling Reveals Stage-Associated Triglyceride Accumulation in Macrophages in a Mouse Model of Ovarian Cancer.

|Jul 02, 2025
Lipid droplet-associated hydrolase (LDAH) knockdown enhances TAG hydrolysis and promotes ovarian cancer progression and chemoresistance.

Bhawna Deswal, Sameera Nallanthighal, Elahe Nikpayam

|Aug 26, 2023
Targeting Heat Shock Protein 27 and Fatty Acid Oxidation Augments Cisplatin Treatment in Cisplatin-Resistant Ovarian Cancer Cell Lines.

James Patrick Heiserman, Zenab Minhas, Elahe Nikpayam

|Mar 10, 2022
Cancer-Associated Fibroblasts: Mechanisms of Tumor Progression and Novel Therapeutic Targets.

Ralf-Peter Czekay, Dong-Joo Cheon, Rohan Samarakoon

|Oct 13, 2021
Heat Shock Protein 27, a Novel Downstream Target of Collagen Type XI alpha 1, Synergizes with Fatty Acid Oxidation to Confer Cisplatin Resistance in Ovarian Cancer Cells.

James Patrick Heiserman, Sameera Nallanthighal, Cody C Gifford

|Mar 06, 2021
Collagen Type XI Alpha 1 (COL11A1): A Novel Biomarker and a Key Player in Cancer.

Sameera Nallanthighal, James Patrick Heiserman, Dong-Joo Cheon

Pageof 2

Frequent Collaborators

2 joint publications

Eun Young Park

2 joint publications

Sun Young Kwon

2 joint publications

Sameera Nallanthighal

2 joint publications

Jaeyeon Kim